Analysis – Page 2 – Goldea Capital

RPX Gold Announces Upsize of Previously Announced “Best Efforts” LIFE Offering and Private Placement to C$12,300,000

Written by Customer Service on April 17, 2026. Posted in Public Companies.

/ NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / TORONTO, April 17, 2026 (GLOBE NEWSWIRE) — RPX Gold Inc. (“RPX Gold” or the “Company”) (TSXV: RPX) is pleased to announce that it has entered into an amendment agreement with Haywood Securities Inc. (“Haywood”), as lead agent and sole bookrunner, on its own behalf and on behalf of a syndicate of agents, including Research Capital Corporation and Paradigm Capital Inc. (together with Haywood, the “Agents”), pursuant to which the Agents have agreed to increase the size of the previously announced “best efforts” private placement offering of securities of the Company (the “Offered Securities”) to maximum gross proceeds to the Company of C$12,300,000 (the “Upsized Offering”). Pursuant to the Upsized Offering, the Offered...

Japan Smaller Capitalization Fund, Inc. Announces Board Determination to Proceed with Conditional Tender Offer

Written by Customer Service on April 17, 2026. Posted in Public Companies.

CONDITIONAL TENDER OFFER FOR 10% OF OUTSTANDING SHARES NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) — Japan Smaller Capitalization Fund, Inc. (the “Fund”) (NYSE: JOF) today announced that its Board of Directors (the “Board”) has approved a cash tender offer to purchase up to 10% of the Fund’s outstanding shares. This tender offer is being conducted pursuant to the Fund’s previously announced Conditional Tender Offer (the “CTO”). The conditions of the CTO were satisfied as the average trading discount of the Fund’s shares exceeded 9% during the period from July 1, 2025 through March 31, 2026 (the “Measurement Period”). The Fund’s average trading discount during the Measurement Period was 10.5%. Following a meeting of the Board scheduled for late May 2026, the Fund expects to announce additional regarding the tender offer, including...

Sysco Declares Increase to Quarterly Dividend Payment

Written by Customer Service on April 17, 2026. Posted in Dividend Reports And Estimates.

HOUSTON, April 17, 2026 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE:SYY) today announced that its Board of Directors declared a quarterly cash dividend of $0.55 per share, representing a $0.01 increase from the prior quarterly dividend of $0.54 per share. The new dividend is payable for the first time on July 24, 2026, to common stockholders of record at the close of business on July 2, 2026. “The Board’s decision today to increase the dividend underscores Sysco’s commitment to delivering consistent shareholder returns, maintaining our status as a Dividend Aristocrat, and executing a disciplined, balanced approach to capital allocation. Our decision today further rewards our shareholders with a planned annual dividend increase of $0.04 for fiscal year 2027,” said Brandon Sewell, Sysco’s interim chief financial officer. About...

Lincoln Educational Services Corporation Schedules First Quarter 2026 Earnings Release And Conference Call

Written by Customer Service on April 17, 2026. Posted in Public Companies.

PARSIPPANY, N.J., April 17, 2026 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (Nasdaq: LINC) (“Lincoln”) announced today that it will host a conference call to discuss its first quarter financial results on Monday, May 11, 2026 at 10:00 a.m. Eastern time. A news release outlining Lincoln’s results will be issued before 9:30 a.m. Eastern time on that day. To access the live webcast of the conference call, please go to the investor relations section of Lincoln’s website at http://www.lincolntech.edu. Participants may also register via teleconference at: Q1 2026 Lincoln Educational Services Earnings Conference Call. Once registration is completed, participants will be provided with a dial-in number containing a personalized PIN to access the call. Participants are requested to register a day in advance or at a minimum...

Talen Energy Announces Pricing of Senior Notes

Written by Customer Service on April 17, 2026. Posted in Mergers And Acquisitions.

HOUSTON, April 17, 2026 (GLOBE NEWSWIRE) — Talen Energy Corporation (“TEC,” “we,” or “our”) (NASDAQ: TLN), announced today that Talen Energy Supply, LLC (“TES” or the “Company”), a direct wholly owned subsidiary of TEC, has priced issuances of $1,500,000,000 in aggregate principal amount of 6.125% senior notes due 2031 (the “2031 Notes”) and $2,500,000,000 in aggregate principal amount of 6.375% senior notes due 2033 (the “2033 Notes” and together with the 2031 Notes, the “Notes”) in private placement transactions not involving a public offering. The issuance and sale of the Notes is expected to close on April 29, 2026, subject to customary closing conditions. The Company intends to use the net proceeds from the issuance and sale of the Notes to fund (i) the previously announced acquisition (the “Acquisition”) by which the Company...

VALUE LINE, INC. DIVIDEND HAS JUST BEEN RAISED FROM $1.30 TO $1.40 (ANNUALIZED) – ITS 12TH CONSECUTIVE INCREASE

Written by Customer Service on April 17, 2026. Posted in Dividend Reports And Estimates.

NEW YORK, April 17, 2026 (GLOBE NEWSWIRE) — Value Line, Inc. (NASDAQ – VALU) announced today that its Board of Directors has just raised its quarterly dividend, which will be $0.35 per common share ($1.40 annualized). The new higher cash dividend is payable on May 12, 2026 to stockholders of record on April 27, 2026. The increase of 7.7% is the 12th consecutive annual increase in Value Line’s dividend. Value Line is a leading provider of investment research. The Value Line Investment Survey is one of the most widely used sources of independent equity research. Value Line publishes proprietary investment research in print and digital formats. Value Line provides these specialized services: a. Value Line Select – Each month, Value Line analysts recommend the one exceptional stock with superior profit potential and...

Hingham Savings Reports First Quarter 2026 Results

Written by Customer Service on April 17, 2026. Posted in Earnings Releases And Operating Results.

HINGHAM, Mass., April 17, 2026 (GLOBE NEWSWIRE) — HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the quarter ended March 31, 2026. Earnings Net income for the quarter ended March 31, 2026 was $2,851,000 or $1.30 per share basic and $1.29 per share diluted, as compared to $7,124,000 or $3.27 per share basic and $3.24 per share diluted for the same period last year. The Bank’s annualized return on average equity for the first quarter of 2026 was 2.33%, and the annualized return on average assets was 0.25%, as compared to 6.46% and 0.64% for the same period in last year. Net income per share (diluted) for the first quarter of 2026 decreased by 60.2% compared to the same period in 2025. Core net income for the quarter ended March 31, 2026, which represents net income excluding the after-tax...

NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET

Written by Customer Service on April 17, 2026. Posted in Public Companies.

LANGHORNE, Pa., April 17, 2026 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it is moving up its shareholder update conference call from Thursday, April 23rd to Tuesday, April 21st, 2026, at 4:30 P.M. ET. Shareholder Update Call Details:Date: April 21, 2026Time: 4:30 P.M. ETLive Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)Webcast: Events and Presentations About NEXGEL, Inc.NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne,...

Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026

Written by Customer Service on April 17, 2026. Posted in Public Companies.

Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion beyond ovarian cancerReal-world data demonstrate Cyclin E1-positive ovarian cancer patients have significantly worse outcomes, independent of CCNE1 gene amplification status, reinforcing the potential for azenosertib to address the unmet need for these patientsSAN DIEGO, April 17, 2026 (GLOBE NEWSWIRE) — Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven treatment approach for ovarian cancer, today announced data from two posters being presented at the 2026 American Association for Cancer Research (AACR) Annual Meeting, taking place April 17-22,...

Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial

Written by Customer Service on April 17, 2026. Posted in Public Companies.

New phase 2 data from personalized cancer vaccine EVX-01 demonstrates a record-high rate of vaccine targets triggering a tumor-specific immune response The results reinforce that Evaxion’s pioneering AI platform, AI-Immunology™ accurately identifies and selects the most relevant vaccine targets Data will be presented at the American Association for Cancer Research (AACR) Annual MeetingCOPENHAGEN, Denmark, April 17, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, announces new data demonstrating that AI-Immunology™ identifies and selects the most therapeutically relevant vaccine targets. The data will be presented at the AACR Annual Meeting in San Diego, California, on April 22, 2026. 86% of the vaccine targets...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals